
Faculty convened at an OncLive Scientific Interchange and Workshop to weigh how new regimens should reshape sequencing in prostate cancer.
Robert Dreicer, MD from the Taussig Cancer Institute on the Need to Diagnose and Treat Prostate Cancer Efficiently